logo

This website uses cookies to ensure you get the best experience on our website.

Read through the Privacy Policy to understand better

 Go Back

Pfizer seeks FDA approval for its Covid-19 pill Paxlovid

By Shubhangi Mathur - Jun 30, 2022, 08:50 PM ET
Last Updated - Jun 07, 2024, 06:35 AM EDT
PFE_logo
Pfizer Inc (NYSE: PFE) has sought the Food and Drug Administration to grant full approval of its Covid-19 antiviral pill

If granted approval, Pfizer will be allowed to sell the drug Paxlovid commercially

If granted approval, Pfizer will be allowed to sell the drug Paxlovid commercially

Pfizer Inc (NYSE: PFE) has sought the Food and Drug Administration to grant full approval of its Covid-19 antiviral pill.

Sponsored

If granted approval, Pfizer will be allowed to sell the drug Paxlovid commercially.

Until now, the federal government has authorized the pill for emergency use and also has been directing the pills’ distribution.

By continuing to use this site, you agree to our terms and conditions
Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250324